Bayer Pharma Aktiengesellschaft

Bayer Intellectual Property Gmbh

Bayer Aktiengesellschaft

Aicuris Gmbh + Co. Kg.

Bayer Schering Pharma Ag

Kersten Matthias Gericke

Christoph Gerdes

Anja Buchmüller

Susanne Röhrig

Katja Zimmermann

Mark Jean Gnoth

Mario Jeske

Dirk Heimbach

Eckhard Bender

Dmitry Zubov

Michael Gerisch

Georges Von Degenfeld

Adrian Tersteegen

Thomas Neubauer

Mark Meininghaus

Philip Lienau

Pierre Wasnaire

Ulf Bömer

Hans Briem

Markus Follmann

Yolanda Cancho Grande

Stefan Heitmeier

Niels Lindner

Ulrich Rester

Dirk Schneider

Alexandros Vakalopoulos

Klemens Lustig

Alexander Hillisch

Lars Bärfacker

Kai Thede

Hans-Christian Militzer

Martina Schäfer

Heinrich Meier

Bernd Riedl

Joerg Keldenich

Hartmut Schirok

Hartmut Beck

Heiko Schirmer

Chantal Fürstner

Joachim Telser

Mario Lobell

Jürgen Klar

Swen Allerheiligen

Carsten Terjung

Martina Victoria Schmidt

Daniela Paulsen

Damian Brockschnieder

Lutz Lehmann

Karen Engel

Dirk Brohm

Philipp Rubenbauer

Dieter Moosmayer

Tom Kinzel

Susanne Greschat

Steffen Wildum

Julia Strassburger

Hannah Jörißen

Marie-Pierre Collin-Kröpelin

Florian Kölling

Julia Straßburger

Hideki Miyatake Ondozabal

Michael Böttger

Thomas Schlange

Andreas Schall

Guillaume Levilain

Jörg Meding

Nicole Biber

Volker Badock

Elisabeth Kersten

Steffen Müller

Frank Süßmeier

Julia Dietze-Torres

Stefanie Mesch

Nils Pfaff

Stefanie Zimmermann

Kartrin Partikel

Andreas Peter Broehl

Dmitrij Hristodorov

Hanna Eilken

Alexander Schulz

Stephen Moore

Andreas Timmermann

Katrin Partikel

Dimitry Zubov

The invention relates to substituted S-alaninate derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular vascular disorders, preferably thrombotic or thromboembolic disorders and/or thrombotic or thromboembolic complications.

Substituted S-alaninate derivatives

The present application relates to novel substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridin-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-c][1,2,4]triazol-3-ones of formula (I), to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of lung inflammation disorders. 

Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof

The present application relates to a novel and improved process for preparing 5-(hydroxyalkyl)-1-phenyl-1,2,4-triazole derivatives of the formula (I) 

Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4-triazole derivatives

The present application relates to novel (3-hydroxyphenyl)amino-substituted pyrido[2,3-b][1,5]benzodiazepin-5-one derivatives, to processes for preparation thereof, to the use thereof alone or in combination for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially of angiogenic disorders and hyperproliferative disorders in which neovascularization plays a role, for example ophthalmological disorders and cancers and tumours. Such treatments can be effected as monotherapy or else in combination with other medicaments or further therapeutic measures.

Substituted pyridobenzodiazepinone-derivatives and use thereof

The invention relates to substituted benzoxazoles and to processes for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of cardiovascular disorders, preferably of thrombotic or thromboembolic disorders.

Substituted benzoxazoles

The invention relates to novel substituted piperidines, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of cardiovascular disorders and tumor disorders.

Substituted piperidines as Par-1 antagonists

The present invention relates to novel substituted furancarboxamides, methods for their production, their use for the treatment and/or prevention of diseases, as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially retroviral diseases, in humans and/or animals.

Substituted (thiazolyl-carbonyl)imidazolidinones and use thereof

The invention relates to novel substituted piperidines, to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular diseases and tumour diseases.

Substituted piperidines

The invention relates to compounds of the formula to processes for the preparation thereof, and to the use thereof for treatment and/or prophylaxis of cardiovascular diseases and tumour diseases.

The invention relates to novel heteroaryl-substituted piperidines, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of cardiovascular diseases and tumor diseases.

Heteroaryl-substituted piperidines

The invention relates to compounds of the formula (I) to processes for the preparation thereof, and to the use thereof for the treatment of cardiovascular disorders and tumor disorders.

Growing community of inventors

Wuppertal, Germany

Kersten Matthias Gericke